- EPA:AXA falls by 0.57% on Thursday as European financial markets drop.
- European travel and insurance industry is getting hit hard by the COVID-19 pandemic.
- AXA is dealing with allegations of back tax fraud in Luxembourg.
EPA:AXA has been a steady stock to own during the COVID-19 pandemic, and despite a dip back in March, shares have been fairly level compared to other publicly traded companies. On Thursday, AXA fell by 0.57% as it took a brief pause from a positive rally that has been taking place over the last months or so since the stock plummeted near the end of October. Like many companies, AXAHY has seen its business directly affected by the coronavirus pandemic that is now experiencing a renewed wave in Europe, but especially in its home country of France where they have seen over 520,000 new cases in the last 14 days.
AXAHY is an insurance giant in France although it operates in many countries around the world. Like with many companies in the insurance sector, AXA has been hit hard by a lack of travel both domestically and internationally throughout the pandemic. Insurance for travellers is a key part of their business and revenues streams, and just as the airline and hotel industries have suffered, so too have insurance companies. Currently, a majority of the analysts that cover Axahy as a stock have a buy rating on the company, as positive developments in terms of a COVID-19 vaccine have boosted optimism for a return to normalcy in 2021.
AXAHY stock price
AXA SA is currently embroiled in accusations of not paying taxes in the country of Luxembourg during the early part of the 21st century. While it is never great publicity for this type of news to emerge, AXA is adamantly disputing the ruling that was made in court. While this should not have a direct impact on Axa moving forward, events like this can sometimes give pause to investors who are on the fence about investing in a company.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.